This report studies the Hirudin market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Hirudin market by product type and applications/end industries.
After re-verification, we found that the company (Aspen Holdings, Bristol-Myers Squibb Company, Eisai Inc, Mitsubishi Tanabe Pharma Corporation, Bayer Healthcare AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Sanofi S.A.) in the sample does not produce hirudin drugs, so we updated the company list as follows:
The major players in global Hirudin market include The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Hirudin in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan
On the basis of product, the Hirudin market is primarily split into Natural Hirudin Recombinant Hirudin
On the basis on the end users/applications, this report covers Thrombosis Disease Tumor Disease Others